Cargando…
Progress in pediatric rheumatology: apprehend the opportunities of the future without forgetting the lessons from the past
Autores principales: | Huppertz, Hans-Iko, Föll, Dirk, Girschick, Hermann, Minden, Kirsten, Horneff, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291844/ https://www.ncbi.nlm.nih.gov/pubmed/21901354 http://dx.doi.org/10.1007/s00296-011-2062-0 |
Ejemplares similares
-
Case of Būnŏsŭs, Apprehended to Be Spurious
Publicado: (1805) -
Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement
por: Horneff, Gerd, et al.
Publicado: (2012) -
Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
por: Horneff, Gerd, et al.
Publicado: (2016) -
Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany
por: Sengler, Claudia, et al.
Publicado: (2021) -
Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
por: Horneff, G, et al.
Publicado: (2008)